Detalhe da pesquisa
1.
Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands.
Anticancer Drugs
; 29(6): 579-588, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29634490
2.
Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.
Anticancer Drugs
; 29(6): 572-578, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659371
3.
Xerosis and pruritus as major EGFRI-associated adverse events.
Support Care Cancer
; 24(2): 513-521, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26111953
4.
Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study.
J Immunother
; 43(8): 256-264, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804914
5.
Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.
Cancers (Basel)
; 11(7)2019 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31323802
6.
[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry]. / Recente behandelresultaten van uitgezaaid melanoom.
Ned Tijdschr Geneeskd
; 1622018 Jun 15.
Artigo
em Holandês
| MEDLINE | ID: mdl-30040270
7.
Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer.
Med Decis Making
; 37(3): 179-192, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27681991
8.
Illness Perceptions in Women with Breast Cancer-a Systematic Literature Review.
Curr Breast Cancer Rep
; 7(3): 117-126, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316925